Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2025-12-28 @ 12:10 AM
Study NCT ID:
NCT00127192
Status:
COMPLETED
Last Update Posted:
2015-06-15
First Post:
2005-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0431-044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None